Blog
RSS FeedPosted by Michael Wonder on 08 Dec 2017
Decision to fund methylnaltrexone in palliative care
8 December 2017 - PHARMAC is pleased to announce the approval of an agreement with Link Pharmaceuticals Limited for the ...
Posted by Michael Wonder on 09 Nov 2017
Decision to fund zoster vaccine
9 November 2017 - PHARMAC is pleased to announce the approval of an agreement with Merck Sharpe & Dohme to ...
Posted by Michael Wonder on 13 Oct 2017
Decision to fund dexamethasone implants (Ozurdex)
13 October 2016 - PHARMAC is pleased to announce the approval of an agreement with Allergan for the listing of ...
Posted by Michael Wonder on 06 Oct 2017
Agreements for the supply of orthopaedic implants and associated products
6 October 2017 - PHARMAC is pleased to announce the approval of agreements with Medtronic New Zealand Limited (“Medtronic”) and ...
Posted by Michael Wonder on 15 Jun 2017
Bendamustine funding approved
15 June 2017 - PHARMAC is pleased to announce the approval of an agreement with Janssen-Cilag for the listing of ...
Posted by Michael Wonder on 12 Jun 2017
Changes to the National Immunisation Schedule - meningococcal C conjugate vaccine
12 June 2017 - PHARMAC is pleased to announce a decision related to the National Immunisation Schedule (NIS) that will ...
Posted by Michael Wonder on 12 Jun 2017
Proposal for various medicines in the neurology, immunology and nephrology therapeutic areas approved
12 June 2017 - PHARMAC is pleased to announce the approval of a proposal relating to certain medicines in the ...
Posted by Michael Wonder on 29 Apr 2017
Decision to list 5-aminolevulinic acid hydrochloride (Gliolan) on the Hospital Medicines List
28 April 2017 - PHARMAC is pleased to announce that the approval of an agreement with Specialised Therapeutics Limited for ...
Posted by Michael Wonder on 23 Apr 2017
New melanoma drug gets Medsafe registration for lung cancer
21 April 2017 - A new drug which was recently funded for melanoma treatment is now registered for lung cancer ...
Posted by Michael Wonder on 19 Apr 2017
PHARMAC reject request to fund women's hygiene products
19 April 2017 - The government's drug-buying agency has rejected a request to fund women's hygiene products. ...
Posted by Michael Wonder on 15 Mar 2017
More options for pregnant women and 65+ to get funded influenza vaccines
15 March 2017 - Funded influenza vaccinations will be available from more community pharmacies this year. ...
Posted by Michael Wonder on 13 Feb 2017
Outcomes from the November 2016 PTAC meeting
13 February 2017 - PHARMAC has published the minutes from the 3-4 November meeting. ...
Posted by Michael Wonder on 10 Feb 2017
Decision to maintain full subsidy for gefitinib (Iressa) from 1 April 2017
10 February 2017 - PHARMAC is pleased to announce the approval of a proposal to maintain full subsidy for gefitinib ...
Posted by Michael Wonder on 08 Feb 2017
Decision relating to nicotine replacement therapy RFP
8 February 2017 - PHARMAC has decided to not accept any proposal in response to, and to terminate the process ...
Posted by Michael Wonder on 26 Jan 2017
Approval of proposal for clostridium botulinum type A toxin (Botox) in DHB hospitals
26 January 2017 - PHARMAC is pleased to announce the approval of an agreement with Allergan to amend the contractual ...